Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Rommel

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Circulation|February 13, 2008
Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processesAnne Fougerat, Stéphanie Gayral, Pierre Gourdy, et al.
Nature Immunology|February 14, 2006
Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1Kate L Jeffrey, Tilman Brummer, Michael S Rolph, et al.
Nature Cell Biology|December 19, 2006
PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesisG John Ferguson, Laura Milne, Suhasini Kulkarni, et al.
Nature Medicine|August 30, 2005
PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupusDomingo F Barber, Almira Bartolomé, Carmen Hernandez, et al.
Journal of Neuroscience Research|June 15, 2010
Chemical inducers and transcriptional markers of oligodendrocyte differentiationLara Joubert, Isabelle Foucault, Yves Sagot, et al.
Oncotarget|July 9, 2016
MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cellsZhihong Zeng, Rui-Yu Wang, Yi Hua Qiu, et al.
American Journal of Respiratory and Critical Care Medicine|February 27, 2007
Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infectionUlrich A Maus, Myriam Backi, Christine Winter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2012
Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasisHannah E Cummings, Joseph Barbi, Patrick Reville, et al.
Nature Medicine|January 15, 2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R Janes, Jose J Limon, Lomon So, et al.
Blood|November 3, 2011
Defining the role of TORC1/2 in multiple myelomaPatricia Maiso, Yi Liu, Brittany Morgan, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Circulation|February 13, 2008
Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processesAnne Fougerat, Stéphanie Gayral, Pierre Gourdy, et al.
Nature Immunology|February 14, 2006
Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1Kate L Jeffrey, Tilman Brummer, Michael S Rolph, et al.
Nature Cell Biology|December 19, 2006
PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesisG John Ferguson, Laura Milne, Suhasini Kulkarni, et al.
Nature Medicine|August 30, 2005
PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupusDomingo F Barber, Almira Bartolomé, Carmen Hernandez, et al.
Journal of Neuroscience Research|June 15, 2010
Chemical inducers and transcriptional markers of oligodendrocyte differentiationLara Joubert, Isabelle Foucault, Yves Sagot, et al.
Oncotarget|July 9, 2016
MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cellsZhihong Zeng, Rui-Yu Wang, Yi Hua Qiu, et al.
American Journal of Respiratory and Critical Care Medicine|February 27, 2007
Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infectionUlrich A Maus, Myriam Backi, Christine Winter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2012
Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasisHannah E Cummings, Joseph Barbi, Patrick Reville, et al.
Nature Medicine|January 15, 2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R Janes, Jose J Limon, Lomon So, et al.
Blood|November 3, 2011
Defining the role of TORC1/2 in multiple myelomaPatricia Maiso, Yi Liu, Brittany Morgan, et al.
Pageof 6